{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "20", "@timestamp": "2020-01-20T04:10:47.000047-05:00", "@year": "2020", "@month": "01"}, "ait:date-sort": {"@day": "01", "@year": "2017", "@month": "01"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Ch-ulalongkorn University"}, {"xocs:funding-agency-matched-string": "Ratcha-daphiseksomphot Endowment Fund"}, {"xocs:funding-agency-matched-string": "Faculty of Medicine", "xocs:funding-agency": "Faculty of Medicine, Prince of Songkla University", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100010804", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}], "xocs:funding-addon-generated-timestamp": "2021-05-09T10:48:51.390519Z", "xocs:funding-text": "The study was supported by the Ratcha-daphiseksomphot Endowment Fund, Faculty of Medicine and the 90thAnniversary of Ch-ulalongkorn University Fund, Thailand.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Inter-department of Pharmacology"}, {"$": "Graduate School"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "117810179"}, "@dptid": "117810179"}, "author": [{"ce:given-name": "Malinee", "preferred-name": {"ce:given-name": "Malinee", "ce:initials": "M.", "ce:surname": "Chunsangchan", "ce:indexed-name": "Chunsangchan M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Chunsangchan", "@auid": "57197794894", "ce:indexed-name": "Chunsangchan M."}]}, {"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacology"}, {"$": "Chulalongkorn University"}, {"$": "Faculty of Medicine"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425668"}, "@dptid": "104425668"}, "author": [{"ce:given-name": "Pajaree", "preferred-name": {"ce:given-name": "Pajaree", "ce:initials": "P.", "ce:surname": "Chariyavilaskul", "ce:indexed-name": "Chariyavilaskul P."}, "@seq": "2", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Chariyavilaskul", "@auid": "55770175000", "ce:indexed-name": "Chariyavilaskul P."}, {"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "3", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Ketchart", "@auid": "37029887800", "ce:indexed-name": "Ketchart W."}, {"ce:given-name": "Supeecha", "preferred-name": {"ce:given-name": "Supeecha", "ce:initials": "S.", "ce:surname": "Wittayalertpanya", "ce:indexed-name": "Wittayalertpanya S."}, "@seq": "5", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Wittayalertpanya", "@auid": "6602827304", "ce:indexed-name": "Wittayalertpanya S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Chula Pharmacokinetic Research Center"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "119708443"}, "@dptid": "119708443"}, "author": [{"ce:given-name": "Nantaporn", "preferred-name": {"ce:given-name": "Nantaporn", "ce:initials": "N.", "ce:surname": "Prompila", "ce:indexed-name": "Prompila N."}, "@seq": "4", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Prompila", "@auid": "15846832700", "ce:indexed-name": "Prompila N."}]}], "citation-title": "Bioequivalence and pharmacokinetic/ pharmacodynamic correlation of clopidogrel in healthy Thai subjects", "abstracts": "\u00a9 2017 Dustri-Verlag Dr. K. Feistle.Clopidogrel is an antiplatelet drug, selectively binding to the platelet P2Y12 receptor of adenosine diphosphate. Clopidogrel is a prodrug modified through active metabolite in the liver by two steps of CYP enzyme. The active metabolite is responsible for inhibiting platelet aggregation. Objective: The study aimed to assess the bioequivalence of clopidogrel 75 mg generic and reference drugs and to investigate the correlation between pharmacokinetics of active metabolites and its antiplatelet activities. Materials and methods: Determination of clopidogrel, carboxylic acid form, and active metabolite were done by liquid chromatography tandem mass spectrometry, and evaluation of platelet function was also investigated by light transmission aggregometer. 20 subjects were randomized and assigned in a crossover design to take a single 75-mg oral dose of clopidogrel generic and reference drugs in two periods with washout. Pharmacokinetic parameters Cmax, AUC0-t, and AUC0-inf of clopidogrel, carboxylic acid form, and active metabolite were analyzed. Results: Bioequivalence could be shown when testing parameters with ANOVA, as 90% confidence intervals were found to be within the acceptance range of 80 - 125%. For the maximum of platelet aggregation after administration of both products, no significant differences were found. Significant correlation of Cmax of clopidogrel active metabolite and maximum platelet aggregation was found after receiving 0 - 6 hours of both formulations. Conclusion: The study found bioequivalence of clopidogrel generic and reference drugs. There were also significant correlations between Cmax of clopidogrel active metabolite and maximum platelet aggregation.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacology"}, {"$": "Chulalongkorn University"}, {"$": "Faculty of Medicine"}]}, "person": {"ce:given-name": "Supeecha", "ce:initials": "S.", "ce:surname": "Wittayalertpanya", "ce:indexed-name": "Wittayalertpanya S."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Bioequivalence", "@xml:lang": "eng"}, {"$": "Clopidogrel active metabolite", "@xml:lang": "eng"}, {"$": "Pharmacodynamics", "@xml:lang": "eng"}, {"$": "Pharmacokinetics", "@xml:lang": "eng"}, {"$": "Platelet aggregation", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://www.dustri.com/nc/journals-in-english/mag/int-journal-of-clinical-pharmacology-and-therapeutics.html", "@type": "email"}}, "translated-sourcetitle": {"$": "International Journal of Clinical Pharmacology and Therapeutics", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "55", "@issue": "12"}, "pagerange": {"@first": "915", "@last": "922"}}, "@type": "j", "sourcetitle": "International Journal of Clinical Pharmacology and Therapeutics", "publicationdate": {"year": "2017", "date-text": {"@xfab-added": "true", "$": "2017"}}, "codencode": "ICTHE", "sourcetitle-abbrev": "Int. J. Clin. Pharmacol. Ther.", "@country": "deu", "issn": {"$": "09461965", "@type": "print"}, "publicationyear": {"@first": "2017"}, "publisher": {"affiliation": {"address-part": "Bajuwarenring 4", "postal-code": "82041", "@country": "deu", "city": "Oberhaching"}, "publishername": "Dustri-Verlag Dr. Karl Feistle", "ce:e-address": {"$": "marina.rottner@dustri.de", "@type": "email"}}, "@srcid": "22434"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": {"classification-code": "99", "classification-description": "General"}}, {"@type": "EMCLASS", "classification": [{"classification-code": "30", "classification-description": "Clinical and Experimental Pharmacology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": [{"$": "3004"}, {"$": "2736"}]}, {"@type": "SUBJABBR", "classification": [{"$": "PHAR"}, {"$": "MEDI"}]}]}, "tradenamegroup": {"tradenames": {"trademanuitem": {"tradename": "plavix", "manufacturer": {"@country": "ita", "$": "Sanofi Winthrop"}}, "@type": "TNM"}}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": [{"$": "113665-84-2"}, {"$": "120202-66-6"}, {"$": "90055-48-4"}, {"$": "94188-84-8"}], "chemical-name": "clopidogrel"}, {"cas-registry-number": [{"$": "53885-35-1"}, {"$": "55142-85-3"}], "chemical-name": "ticlopidine"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "clopidogrel"}, {"chemical-name": "Platelet Aggregation Inhibitors"}, {"chemical-name": "Ticlopidine"}]}]}, "manufacturergroup": {"manufacturers": {"@type": "MNF", "manufacturer": {"@country": "ita", "$": "Sanofi Winthrop"}}}}}, "item-info": {"copyright": {"$": "Copyright 2018 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "REAXYS"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "05", "@timestamp": "BST 16:36:13", "@year": "2018", "@month": "03"}}, "itemidlist": {"itemid": [{"$": "619359007", "@idtype": "PUI"}, {"$": "2017369118", "@idtype": "CABS"}, {"$": "813521699", "@idtype": "CAR-ID"}, {"$": "20170831739", "@idtype": "EMBASE"}, {"$": "29092730", "@idtype": "MEDL"}, {"$": "2017259189", "@idtype": "REAXYS"}, {"$": "20172090497", "@idtype": "REAXYSCAR"}, {"$": "2017336555", "@idtype": "RMC"}, {"$": "20171064005", "@idtype": "SCOPUS"}, {"$": "85034849379", "@idtype": "SCP"}, {"$": "85034849379", "@idtype": "SGR"}, {"$": "620941491", "@idtype": "PUIsecondary"}], "ce:doi": "10.5414/CP203054"}}, "tail": {"bibliography": {"@refcount": "16", "reference": [{"ref-fulltext": "Kim BH, Kim JR, Lim KS, Shin HS, Yoon SH, Cho JY, Jang IJ, Shin SG, Yu KS. Comparative pharmacokinetics/ pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjects. Clin Drug Investig. 2012; 32: 817-826. CrossRef PubMed", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Comparative pharmacokinetics/ pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjects"}, "refd-itemidlist": {"itemid": {"$": "84873451679", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "817", "@last": "826"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.H.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim B.H."}, {"@seq": "2", "ce:initials": "J.R.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim J.R."}, {"@seq": "3", "ce:initials": "K.S.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim K.S."}, {"@seq": "4", "ce:initials": "H.S.", "@_fa": "true", "ce:surname": "Shin", "ce:indexed-name": "Shin H.S."}, {"@seq": "5", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Yoon", "ce:indexed-name": "Yoon S.H."}, {"@seq": "6", "ce:initials": "J.Y.", "@_fa": "true", "ce:surname": "Cho", "ce:indexed-name": "Cho J.Y."}, {"@seq": "7", "ce:initials": "I.J.", "@_fa": "true", "ce:surname": "Jang", "ce:indexed-name": "Jang I.J."}, {"@seq": "8", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Shin", "ce:indexed-name": "Shin S.G."}, {"@seq": "9", "ce:initials": "K.S.", "@_fa": "true", "ce:surname": "Yu", "ce:indexed-name": "Yu K.S."}]}, "ref-sourcetitle": "Clin Drug Investig."}}, {"ref-fulltext": "Peer CJ, Spencer SD, VanDenBerg DA, Pacanowski MA, Horenstein RB, Figg WD. A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 880: 132-139. CrossRef PubMed", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma"}, "refd-itemidlist": {"itemid": {"$": "84855199955", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "880"}, "pagerange": {"@first": "132", "@last": "139"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.J.", "@_fa": "true", "ce:surname": "Peer", "ce:indexed-name": "Peer C.J."}, {"@seq": "2", "ce:initials": "S.D.", "@_fa": "true", "ce:surname": "Spencer", "ce:indexed-name": "Spencer S.D."}, {"@seq": "3", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Van Den Berg", "ce:indexed-name": "Van Den Berg D.A."}, {"@seq": "4", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Pacanowski", "ce:indexed-name": "Pacanowski M.A."}, {"@seq": "5", "ce:initials": "R.B.", "@_fa": "true", "ce:surname": "Horenstein", "ce:indexed-name": "Horenstein R.B."}, {"@seq": "6", "ce:initials": "W.D.", "@_fa": "true", "ce:surname": "Figg", "ce:indexed-name": "Figg W.D."}]}, "ref-sourcetitle": "J Chromatogr B Analyt Technol Biomed Life Sci."}}, {"ref-fulltext": "Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescot G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, Van Werkum JW, Paganelli F, Price MJ, Waksman R, et al; Working Group on High On-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010; 56: 919-933. CrossRef PubMed", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate"}, "refd-itemidlist": {"itemid": {"$": "77953911457", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "919", "@last": "933"}}, "ref-text": "Working Group on High On-Treatment Platelet Reactivity CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Bonello", "ce:indexed-name": "Bonello L."}, {"@seq": "2", "ce:initials": "U.S.", "@_fa": "true", "ce:surname": "Tantry", "ce:indexed-name": "Tantry U.S."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Marcucci", "ce:indexed-name": "Marcucci R."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Blindt", "ce:indexed-name": "Blindt R."}, {"@seq": "5", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Angiolillo", "ce:indexed-name": "Angiolillo D.J."}, {"@seq": "6", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Becker", "ce:indexed-name": "Becker R."}, {"@seq": "7", "ce:initials": "D.L.", "@_fa": "true", "ce:surname": "Bhatt", "ce:indexed-name": "Bhatt D.L."}, {"@seq": "8", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Cattaneo", "ce:indexed-name": "Cattaneo M."}, {"@seq": "9", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Collet", "ce:indexed-name": "Collet J.P."}, {"@seq": "10", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Cuisset", "ce:indexed-name": "Cuisset T."}, {"@seq": "11", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Gachet", "ce:indexed-name": "Gachet C."}, {"@seq": "12", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Montalescot", "ce:indexed-name": "Montalescot G."}, {"@seq": "13", "ce:initials": "L.K.", "@_fa": "true", "ce:surname": "Jennings", "ce:indexed-name": "Jennings L.K."}, {"@seq": "14", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Kereiakes", "ce:indexed-name": "Kereiakes D."}, {"@seq": "15", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Sibbing", "ce:indexed-name": "Sibbing D."}, {"@seq": "16", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Trenk", "ce:indexed-name": "Trenk D."}, {"@seq": "17", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Van Werkum", "ce:indexed-name": "Van Werkum J.W."}, {"@seq": "18", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Paganelli", "ce:indexed-name": "Paganelli F."}, {"@seq": "19", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Price", "ce:indexed-name": "Price M.J."}, {"@seq": "20", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Waksman", "ce:indexed-name": "Waksman R."}], "et-al": null}, "ref-sourcetitle": "J Am Coll Cardiol."}}, {"ref-fulltext": "Kara\u017aniewicz-\u0141ada M, Danielak D, Burchardt P, Kruszyna L, Komosa A, Lesiak M, G\u0142\u00f3wka F. Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases. Clin Pharmacokinet. 2014; 53: 155-164. CrossRef PubMed", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases"}, "refd-itemidlist": {"itemid": {"$": "84893270831", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "53"}, "pagerange": {"@first": "155", "@last": "164"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Kara\u017aniewicz-\u0141Ada", "ce:indexed-name": "Karazniewicz-LAda M."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Danielak", "ce:indexed-name": "Danielak D."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Burchardt", "ce:indexed-name": "Burchardt P."}, {"@seq": "4", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Kruszyna", "ce:indexed-name": "Kruszyna L."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Komosa", "ce:indexed-name": "Komosa A."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lesiak", "ce:indexed-name": "Lesiak M."}, {"@seq": "7", "ce:initials": "F.", "@_fa": "true", "ce:surname": "G\u0142\u00f3wka", "ce:indexed-name": "Glowka F."}]}, "ref-sourcetitle": "Clin Pharmacokinet."}}, {"ref-fulltext": "Delavenne X, Mallouk N, Piot M, Mismetti P, Laporte S. Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests? J Thromb Haemost. 2010; 8: 2334-2338. CrossRef PubMed", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests?"}, "refd-itemidlist": {"itemid": {"$": "78649363570", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "2334", "@last": "2338"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Delavenne", "ce:indexed-name": "Delavenne X."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Mallouk", "ce:indexed-name": "Mallouk N."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Piot", "ce:indexed-name": "Piot M."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Mismetti", "ce:indexed-name": "Mismetti P."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Laporte", "ce:indexed-name": "Laporte S."}]}, "ref-sourcetitle": "J Thromb Haemost."}}, {"ref-fulltext": "Gurbel PA, Antonino MJ, Tantry US. Recent developments in clopidogrel pharmacology and their relation to clinical outcomes. Expert Opin Drug Metab Toxicol. 2009; 5: 989-1004. Cross- Ref PubMed", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Recent developments in clopidogrel pharmacology and their relation to clinical outcomes"}, "refd-itemidlist": {"itemid": {"$": "68149180722", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "989", "@last": "1004"}}, "ref-text": "Cross- Ref PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "Gurbel", "ce:indexed-name": "Gurbel P.A."}, {"@seq": "2", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Antonino", "ce:indexed-name": "Antonino M.J."}, {"@seq": "3", "ce:initials": "U.S.", "@_fa": "true", "ce:surname": "Tantry", "ce:indexed-name": "Tantry U.S."}]}, "ref-sourcetitle": "Expert Opin Drug Metab Toxicol."}}, {"ref-fulltext": "Liang Y, Johnston M, Hirsh J, Pare G, Li C, Mehta S, Teo KK, Sloane D, Yi Q, Zhu J, Eikelboom JW. Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin. J Thromb Thrombolysis. 2012; 34: 429-436. Cross- Ref PubMed", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin"}, "refd-itemidlist": {"itemid": {"$": "84868207441", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "34"}, "pagerange": {"@first": "429", "@last": "436"}}, "ref-text": "Cross- Ref PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Liang", "ce:indexed-name": "Liang Y."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Johnston", "ce:indexed-name": "Johnston M."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hirsh", "ce:indexed-name": "Hirsh J."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Pare", "ce:indexed-name": "Pare G."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li C."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Mehta", "ce:indexed-name": "Mehta S."}, {"@seq": "7", "ce:initials": "K.K.", "@_fa": "true", "ce:surname": "Teo", "ce:indexed-name": "Teo K.K."}, {"@seq": "8", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Sloane", "ce:indexed-name": "Sloane D."}, {"@seq": "9", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Yi", "ce:indexed-name": "Yi Q."}, {"@seq": "10", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Zhu", "ce:indexed-name": "Zhu J."}, {"@seq": "11", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Eikelboom", "ce:indexed-name": "Eikelboom J.W."}]}, "ref-sourcetitle": "J Thromb Thrombolysis."}}, {"ref-fulltext": "Guidance for industry - Bioanalytical method validation. US Department of Health and Human Services, F.a.D.A., Center for Drug Evaluation and Research, Center for Veterinary Medicine; 2001. p. 1-19.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "refd-itemidlist": {"itemid": {"$": "0003484310", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "1", "@last": "19"}}, "ref-text": "US Department of Health and Human Services, F.a.D.A., Center for Drug Evaluation and Research, Center for Veterinary Medicine;", "ref-sourcetitle": "Guidance for Industry - Bioanalytical Method Validation"}}, {"ref-fulltext": "Kara\u017aniewicz-\u0141ada M, Danielak D, Tezyk A, Zaba C, Tuffal G, G\u0142\u00f3wka F. HPLC-MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 911: 105-112. CrossRef PubMed", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "HPLC-MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples"}, "refd-itemidlist": {"itemid": {"$": "84870477806", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "911"}, "pagerange": {"@first": "105", "@last": "112"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Kara\u017aniewicz-\u0141Ada", "ce:indexed-name": "Karazniewicz-LAda M."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Danielak", "ce:indexed-name": "Danielak D."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Tezyk", "ce:indexed-name": "Tezyk A."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Zaba", "ce:indexed-name": "Zaba C."}, {"@seq": "5", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Tuffal", "ce:indexed-name": "Tuffal G."}, {"@seq": "6", "ce:initials": "F.", "@_fa": "true", "ce:surname": "G\u0142\u00f3wka", "ce:indexed-name": "Glowka F."}]}, "ref-sourcetitle": "J Chromatogr B Analyt Technol Biomed Life Sci."}}, {"ref-fulltext": "Heestermans AA, van Werkum JW, Taubert D, Seesing TH, von Beckerath N, Hackeng CM, Sch\u00f6mig E, Verheugt FW, ten Berg JM. Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction. Thromb Res. 2008; 122: 776-781. CrossRef PubMed", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction"}, "refd-itemidlist": {"itemid": {"$": "49249137412", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "122"}, "pagerange": {"@first": "776", "@last": "781"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Heestermans", "ce:indexed-name": "Heestermans A.A."}, {"@seq": "2", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Van Werkum", "ce:indexed-name": "Van Werkum J.W."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Taubert", "ce:indexed-name": "Taubert D."}, {"@seq": "4", "ce:initials": "T.H.", "@_fa": "true", "ce:surname": "Seesing", "ce:indexed-name": "Seesing T.H."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Von Beckerath", "ce:indexed-name": "Von Beckerath N."}, {"@seq": "6", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Hackeng", "ce:indexed-name": "Hackeng C.M."}, {"@seq": "7", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Sch\u00f6mig", "ce:indexed-name": "Schomig E."}, {"@seq": "8", "ce:initials": "F.W.", "@_fa": "true", "ce:surname": "Verheugt", "ce:indexed-name": "Verheugt F.W."}, {"@seq": "9", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Ten Berg", "ce:indexed-name": "Ten Berg J.M."}]}, "ref-sourcetitle": "Thromb Res."}}, {"ref-fulltext": "Administration, U.S.D.o.H.a.H.S.F.a.D., Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations; 2003. p. 1-26.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "refd-itemidlist": {"itemid": {"$": "0003455042", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "1", "@last": "26"}}, "ref-text": "Administration, U.S.D.o.H.a.H.S.F.a.D.", "ref-sourcetitle": "Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations"}}, {"ref-fulltext": "Zou J-J, Tan J, Fan H-W, Chen S-L. Bioequivalence study of clopidogrel 75 mg tablets in healthy male volunteers. Journal of bioequivalence and bioavailability. 2012; 4: 1-4. CrossRef", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Bioequivalence study of clopidogrel 75 mg tablets in healthy male volunteers"}, "refd-itemidlist": {"itemid": {"$": "84861211617", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "1", "@last": "4"}}, "ref-text": "CrossRef", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.-J.", "@_fa": "true", "ce:surname": "Zou", "ce:indexed-name": "Zou J.-J."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tan", "ce:indexed-name": "Tan J."}, {"@seq": "3", "ce:initials": "H.-W.", "@_fa": "true", "ce:surname": "Fan", "ce:indexed-name": "Fan H.-W."}, {"@seq": "4", "ce:initials": "S.-L.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen S.-L."}]}, "ref-sourcetitle": "Journal of Bioequivalence and Bioavailability."}}, {"ref-fulltext": "Ksycinska H, Rudzki P, Bukowska-Kiliszek M. Determination of clopidogrel metabolite (SR26334) in human plasma by LC-MS. J Pharm Biomed Anal. 2006; 41: 533-539. CrossRef PubMed", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Determination of clopidogrel metabolite (SR26334) in human plasma by LC-MS"}, "refd-itemidlist": {"itemid": {"$": "33646001776", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "41"}, "pagerange": {"@first": "533", "@last": "539"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Ksycinska", "ce:indexed-name": "Ksycinska H."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Rudzki", "ce:indexed-name": "Rudzki P."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Bukowska-Kiliszek", "ce:indexed-name": "Bukowska-Kiliszek M."}]}, "ref-sourcetitle": "J Pharm Biomed Anal."}}, {"ref-fulltext": "Kim KA, Park PW, Hong SJ, Park JY. The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance. Clin Pharmacol Ther. 2008; 84: 236-242. Cross- Ref PubMed", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: A possible mechanism for clopidogrel resistance"}, "refd-itemidlist": {"itemid": {"$": "45249088224", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "84"}, "pagerange": {"@first": "236", "@last": "242"}}, "ref-text": "Cross- Ref PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.A.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim K.A."}, {"@seq": "2", "ce:initials": "P.W.", "@_fa": "true", "ce:surname": "Park", "ce:indexed-name": "Park P.W."}, {"@seq": "3", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Hong", "ce:indexed-name": "Hong S.J."}, {"@seq": "4", "ce:initials": "J.Y.", "@_fa": "true", "ce:surname": "Park", "ce:indexed-name": "Park J.Y."}]}, "ref-sourcetitle": "Clin Pharmacol Ther."}}, {"ref-fulltext": "Taubert D, von Beckerath N, Grimberg G, Lazar A, Jung N, Goeser T, Kastrati A, Sch\u00f6mig A, Sch\u00f6mig E. Impact of P-glycoprotein on clopidogrel absorption. Clin Pharmacol Ther. 2006; 80: 486-501. CrossRef PubMed", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Impact of P-glycoprotein on clopidogrel absorption"}, "refd-itemidlist": {"itemid": {"$": "33751080762", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "80"}, "pagerange": {"@first": "486", "@last": "501"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Taubert", "ce:indexed-name": "Taubert D."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Von Beckerath", "ce:indexed-name": "Von Beckerath N."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Grimberg", "ce:indexed-name": "Grimberg G."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lazar", "ce:indexed-name": "Lazar A."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Jung", "ce:indexed-name": "Jung N."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Goeser", "ce:indexed-name": "Goeser T."}, {"@seq": "7", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Kastrati", "ce:indexed-name": "Kastrati A."}, {"@seq": "8", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Sch\u00f6mig", "ce:indexed-name": "Schomig A."}, {"@seq": "9", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Sch\u00f6mig", "ce:indexed-name": "Schomig E."}]}, "ref-sourcetitle": "Clin Pharmacol Ther."}}, {"ref-fulltext": "Wallentin L, Varenhorst C, James S, Erlinge D, Braun OO, Jakubowski JA, Sugidachi A, Winters KJ, Siegbahn A. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J. 2008; 29: 21-30. CrossRef PubMed", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease"}, "refd-itemidlist": {"itemid": {"$": "37849002889", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "21", "@last": "30"}}, "ref-text": "CrossRef PubMed", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Wallentin", "ce:indexed-name": "Wallentin L."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Varenhorst", "ce:indexed-name": "Varenhorst C."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "James", "ce:indexed-name": "James S."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Erlinge", "ce:indexed-name": "Erlinge D."}, {"@seq": "5", "ce:initials": "O.O.", "@_fa": "true", "ce:surname": "Braun", "ce:indexed-name": "Braun O.O."}, {"@seq": "6", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Jakubowski", "ce:indexed-name": "Jakubowski J.A."}, {"@seq": "7", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Sugidachi", "ce:indexed-name": "Sugidachi A."}, {"@seq": "8", "ce:initials": "K.J.", "@_fa": "true", "ce:surname": "Winters", "ce:indexed-name": "Winters K.J."}, {"@seq": "9", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Siegbahn", "ce:indexed-name": "Siegbahn A."}]}, "ref-sourcetitle": "Eur Heart J."}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-85034849379", "dc:description": "Clopidogrel is an antiplatelet drug, selectively binding to the platelet P2Y12 receptor of adenosine diphosphate. Clopidogrel is a prodrug modified through active metabolite in the liver by two steps of CYP enzyme. The active metabolite is responsible for inhibiting platelet aggregation. Objective: The study aimed to assess the bioequivalence of clopidogrel 75 mg generic and reference drugs and to investigate the correlation between pharmacokinetics of active metabolites and its antiplatelet activities. Materials and methods: Determination of clopidogrel, carboxylic acid form, and active metabolite were done by liquid chromatography tandem mass spectrometry, and evaluation of platelet function was also investigated by light transmission aggregometer. 20 subjects were randomized and assigned in a crossover design to take a single 75-mg oral dose of clopidogrel generic and reference drugs in two periods with washout. Pharmacokinetic parameters Cmax, AUC0-t, and AUC0-inf of clopidogrel, carboxylic acid form, and active metabolite were analyzed. Results: Bioequivalence could be shown when testing parameters with ANOVA, as 90% confidence intervals were found to be within the acceptance range of 80 - 125%. For the maximum of platelet aggregation after administration of both products, no significant differences were found. Significant correlation of Cmax of clopidogrel active metabolite and maximum platelet aggregation was found after receiving 0 - 6 hours of both formulations. Conclusion: The study found bioequivalence of clopidogrel generic and reference drugs. There were also significant correlations between Cmax of clopidogrel active metabolite and maximum platelet aggregation.", "pubmed-id": "29092730", "prism:coverDate": "2017-01-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85034849379", "dc:creator": {"author": [{"ce:given-name": "Malinee", "preferred-name": {"ce:given-name": "Malinee", "ce:initials": "M.", "ce:surname": "Chunsangchan", "ce:indexed-name": "Chunsangchan M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Chunsangchan", "@auid": "57197794894", "author-url": "https://api.elsevier.com/content/author/author_id/57197794894", "ce:indexed-name": "Chunsangchan M."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85034849379"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85034849379&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85034849379&origin=inward"}], "source-id": "22434", "citedby-count": "2", "prism:volume": "55", "subtype": "ar", "dc:title": "Bioequivalence and pharmacokinetic/ pharmacodynamic correlation of clopidogrel in healthy Thai subjects", "openaccess": "0", "prism:issn": "09461965", "publishercopyright": "\u00a9 2017 Dustri-Verlag Dr. K. Feistle.", "prism:issueIdentifier": "12", "subtypeDescription": "Article", "prism:publicationName": "International Journal of Clinical Pharmacology and Therapeutics", "prism:pageRange": "915-922", "prism:endingPage": "922", "openaccessFlag": "false", "prism:doi": "10.5414/CP203054", "prism:startingPage": "915", "dc:identifier": "SCOPUS_ID:85034849379", "dc:publisher": "Dustri-Verlag Dr. Karl FeistleBajuwarenring 4Oberhaching82041marina.rottner@dustri.de"}, "idxterms": {"mainterm": [{"$": "Adolescent", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Cross-Over Studies", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Platelet Aggregation", "@weight": "b", "@candidate": "n"}, {"$": "Platelet Aggregation Inhibitors", "@weight": "b", "@candidate": "n"}, {"$": "Therapeutic Equivalency", "@weight": "b", "@candidate": "n"}, {"$": "Ticlopidine", "@weight": "b", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Bioequivalence"}, {"@_fa": "true", "$": "Clopidogrel active metabolite"}, {"@_fa": "true", "$": "Pharmacodynamics"}, {"@_fa": "true", "$": "Pharmacokinetics"}, {"@_fa": "true", "$": "Platelet aggregation"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmacology (medical)", "@code": "2736", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Malinee", "preferred-name": {"ce:given-name": "Malinee", "ce:initials": "M.", "ce:surname": "Chunsangchan", "ce:indexed-name": "Chunsangchan M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Chunsangchan", "@auid": "57197794894", "author-url": "https://api.elsevier.com/content/author/author_id/57197794894", "ce:indexed-name": "Chunsangchan M."}, {"ce:given-name": "Pajaree", "preferred-name": {"ce:given-name": "Pajaree", "ce:initials": "P.", "ce:surname": "Chariyavilaskul", "ce:indexed-name": "Chariyavilaskul P."}, "@seq": "2", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Chariyavilaskul", "@auid": "55770175000", "author-url": "https://api.elsevier.com/content/author/author_id/55770175000", "ce:indexed-name": "Chariyavilaskul P."}, {"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "3", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Ketchart", "@auid": "37029887800", "author-url": "https://api.elsevier.com/content/author/author_id/37029887800", "ce:indexed-name": "Ketchart W."}, {"ce:given-name": "Nantaporn", "preferred-name": {"ce:given-name": "Nantaporn", "ce:initials": "N.", "ce:surname": "Prompila", "ce:indexed-name": "Prompila N."}, "@seq": "4", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Prompila", "@auid": "15846832700", "author-url": "https://api.elsevier.com/content/author/author_id/15846832700", "ce:indexed-name": "Prompila N."}, {"ce:given-name": "Supeecha", "preferred-name": {"ce:given-name": "Supeecha", "ce:initials": "S.", "ce:surname": "Wittayalertpanya", "ce:indexed-name": "Wittayalertpanya S."}, "@seq": "5", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Wittayalertpanya", "@auid": "6602827304", "author-url": "https://api.elsevier.com/content/author/author_id/6602827304", "ce:indexed-name": "Wittayalertpanya S."}]}}}